AuctuCel Establishes First Distribution Centre in China to Strengthen Regional Supply Chain
Singapore / China — January 2026
AuctuCel, a Singapore-based biotechnology company spun out of A*STAR’s Bioprocessing Technology Institute, has announced the establishment of its first distributioncentre in China , marking a key milestone in the company’s regional expansion.
The new distribution centre strengthens AuctuCel’s ability to support customers across China and the wider Asia region, enabling shorter lead times, greater supply consistency, and improved regional responsiveness. This development reinforces the company’s commitment to building a reliable and scalable supply chain as demand for its products continues to grow.
By establishing a local distribution footprint, AuctuCel is better positioned to serve academic and industrial customers with timely access to high-quality bioprocessing solutions, while maintaininginternationally aligned standards.
“Building a strong distribution backbone is essential as we scale,” said Dr Fhu Chee Wai , Co-founder and Chief Executive Officer of AuctuCel. “This milestone reflects our focus on operational readiness and our responsibility to support customers with consistency, reliability, and quality as we grow across the region.”
Dr Zach Pang, Co-founder and Chief Scientific Advisor of AuctuCel, added, “Effective bioprocessing doesn’t stop at innovation in the lab — it requires dependable delivery and execution. Strengthening our regional distribution capability allows scientific solutions to reach customers more efficiently and reliably.”
The establishment of the distribution centre represents an important step in AuctuCel’s long-term strategy to scale thoughtfully, with infrastructure that grows alongside customer needs.
---
About AuctuCel
AuctuCel is a Singapore-based biotechnology company spun out of A*STAR’s Bioprocessing Technology Institute. The company aims to transform bioprocessing through advanced modelling and scientific expertise, redefining culture media optimisation to unlock greater efficiency, lower costs, and intelligent, data-driven innovation.
————
AuctuCel 在中国设立首个区域配送中心
新加坡 / 中国｜2026 年 1 月
新加坡生物科技公司 AuctuCel（源自 A*STAR 生物制程技术研究院）宣布，已在中国设立其首个区域配送中心，进一步强化在中国及亚太地区的供应链与交付能力。
该配送中心将支持更高效、稳定的产品交付，提升区域响应速度，更好地服务科研与产业客户不断增长的需求。
AuctuCel 联合创办人兼首席执行官 Dr Fhu Chee Wai 表示：
「随着业务规模的扩大，建立稳健可靠的区域配送体系至关重要。此次设立配送中心，是我们持续强化运营能力、确保客户获得稳定高质量产品的重要一步。」
联合创办人兼首席科学顾问 Dr Zach Pang 补充：
「生物制程的价值不仅体现在实验室创新，更体现在执行与交付能力上。完善的区域配送体系，能够让科研成果更高效地转化为实际应用。」
长过程中，对稳健运营与长期发展的重视，并将持续以负责任、可持续的方式推进区域扩展。
